NEUCEN Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for NEUCEN with the United States Patent and Trademark Office. The USPTO has given the NEUCEN trademark a serial number of 97311899. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2023. This trademark is owned by NeuCen Biomedical Inc.. The NEUCEN trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and allergy; Medical preparations for the treatment of cancer and allergy; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
neucen

General Information


Serial Number97311899
Word MarkNEUCEN
Filing DateMonday, March 14, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements


Description of MarkThe mark consists of a design comprising a solid red rectangular shape with C-shaped, curved, ends and rectangular slots centered at the top and bottom and approximately half the length of the full design. a thin white line inside the design follows the curved ends from the top slot to the bottom slot and in the middle is the literal component "NeuCen" in white where the top of the upper case N has a horizontal line segment extending from the upper right end to the C, and the lower case n has a horizontal line segment extending from the bottom left end to a point between the u and the C.
Goods and ServicesChemical preparations for pharmaceutical or medical purposes, namely, for cancer and allergy; Medical preparations for the treatment of cancer and allergy; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Indication of Colors claimedThe color(s) red and white is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuCen Biomedical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City
TW

Party NameNeuCen Biomedical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City
TW

Trademark Events


Event DateEvent Description
Monday, October 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2022ASSIGNED TO EXAMINER
Saturday, March 19, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2022NEW APPLICATION ENTERED